{
    "2018-09-12": [
        [
            {
                "time": "2018-09-13",
                "original_text": "How Companies Are Getting Ready for Hurricane Florence",
                "features": {
                    "keywords": [
                        "Hurricane Florence",
                        "Companies",
                        "Ready"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "insurance",
                        "utilities"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-14",
                "original_text": "Pfizer's Drug Combo Betters Survival in Kidney Cancer Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Drug Combo",
                        "Kidney Cancer",
                        "Study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "Dow Movers: INTC, CVX",
                "features": {
                    "keywords": [
                        "Dow Movers",
                        "INTC",
                        "CVX"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-16",
                "original_text": "The Outlook for AstraZeneca Is Positive, But Itâ€™s Too Early to Pull the Trigger",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "Positive Outlook",
                        "Early"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-17",
                "original_text": "Exact Sciences Posted 52.2% Returns in the Last Month",
                "features": {
                    "keywords": [
                        "Exact Sciences",
                        "Returns",
                        "Last Month"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-09-18",
                "original_text": "Pfizer's Drug Combo Betters Survival in Kidney Cancer Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Drug Combo",
                        "Kidney Cancer",
                        "Study"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}